Pharmacyte Biotech, Inc. entered into a Securities Purchase Agreement with MyMD Pharmaceuticals, Inc. to purchase shares of MyMD's newly designated Series G Convertible Preferred Stock, warrants to purchase MyMD Common Shares, and warrants to purchase MyMD Common Shares for a total of $7,000,000.